Nordic Capital to sell Sunrise Medical, one of the globally leading providers of assistive mobility solutions, to Platinum Equity

Nordic Capital, a leading sector-specialised private equity investor, has entered into an agreement to sell Sunrise Medical, a global leader in assistive mobility solutions, to global investment firm Platinum Equity. Under Nordic Capital’s ownership, Sunrise Medical strongly developed its presence in the field of complex rehabilitation where products are often tailor-made to the specific requirements of individual mobility-impaired customers with chronic needs. This marks the culmination of a great partnership, the start of an exciting next phase for Sunrise Medical and a successful outcome for Nordic Capital.

 

Sunrise Medical is one of the leading companies in complex rehabilitation with a broad portfolio of products across complex and standard rehabilitation supported by a strong global footprint. The Company is active in the development, design, manufacturing, and distribution of assistive mobility products and solutions such as manual and power wheelchairs, power assist products, pediatric and geriatric therapeutic devices, mobility scooters, seating and positioning systems as well as daily living aids and other home medical equipment. Sunrise Medical’s long-term success in the market is driven by continuous innovation and the company employs over 110 associates focused on research & development (R&D) and engineering as well as operates eleven R&D sites in six countries. Following Nordic Capital’s acquisition in 2015, revenue have almost doubled from EUR 364 mn to EUR 636 mn in FY 2022/23 with improved profitability. The number of employees increased from 2,000 to more than 2,800 worldwide today.

 

By leveraging Nordic Capital’s sector expertise, commercial excellence, and experience from supporting companies on international growth journeys, Sunrise Medical has successfully strengthened its global footprint and has today a direct presence in 23 countries. The company’s products are sold in over 130 countries to an extensive network of healthcare dealers, government agencies and public institutions. In close partnership with the management team, Nordic Capital has focused on operational excellence and platform investments, with a vision to position the company as one of the global leaders in a highly regulated and advanced sector. Sunrise Medical has also incorporated ESG measures at the core of its organisational framework, business strategy, and M&A agenda. The company has specifically focused on enhancing its social contributions, bolstering its environmental commitments, and strengthening its quality management.

 

For more information: https://www.nordiccapital.com/news-views/press-releases/nordic-capital-to-sell-sunrise-medical-one-of-the-globally-leading-providers-of-assistive-mobility-solutions/?utm_medium=email&utm_campaign=Update%20Nordic%20Capital%20to%20sell%20Sunrise%20Medical%20one%20of%20the%20globally%20leading%20providers%20of%20assistive%20mobility%20solutions%202024-06-05%20060722&utm_content=Update%20Nordic%20Capital%20to%20sell%20Sunrise%20Medical%20one%20of%20the%20globally%20leading%20providers%20of%20assistive%20mobility%20solutions%202024-06-05%20060722+CID_503137855ae1115d1a3ba91ee9a857ff&utm_source=email&utm_term=Read%20Full%20Article